Amarin reported $-31563000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
DBV Technologies DBVT:US -16706000 3.03M
Abbvie ABBV:US $ 4490M 446M
Aerie Pharmaceuticals AERI:US $ -35.89M 81.42M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Amarin AMRN:US $ -31.56M 46.26M
AstraZeneca AZN:LN 386M 733M
Biocryst Pharmaceuticals BCRX:US $ -74.2M 56.42M
Epizyme EPZM:US $ -55.5M 4.85M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
GlaxoSmithKline GSK:LN 1802M 1053M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
JAZZ PHA JAZZ:US $ 1.65M 37M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Teva Pharmaceutical Industries TEVA:US $ -955M 797M